| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
61,456,000 |
| Market
Cap: |
929.83(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.9 - $15.24 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CareDx together with its subsidiaries, is a medicine company focused on the discovery, development and commercialization of diagnostic solutions for transplant patients and caregivers. Co. provides testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey, and is a provider of genomics-based information for transplant patients. Co.'s commercially available testing services consist of AlloSure® Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients, AlloMap® Heart, a solution for heart transplant patients, AlloSure® Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure® Lung.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
41,629 |
106,345 |
| Total Sell Value |
$0 |
$0 |
$382,438 |
$1,585,048 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
10 |
21 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Maag Peter |
Executive Chair |
• • – |
2020-11-05 |
4 |
AS |
$53.27 |
$534,791 |
D/D |
(10,000) |
421,974 |
|
22% |
|
| Maag Peter |
Executive Chair |
• • – |
2020-11-05 |
4 |
OE |
$5.90 |
$60,757 |
D/D |
10,000 |
431,974 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2020-11-03 |
4 |
AS |
$48.15 |
$1,568,487 |
D/D |
(32,574) |
103,343 |
|
44% |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2020-11-03 |
4 |
OE |
$1.00 |
$429,549 |
D/D |
25,640 |
135,917 |
|
- |
|
| Seeto Reginald |
See Remarks |
• • – |
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,100 |
127,949 |
|
- |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2020-10-08 |
4 |
AS |
$50.62 |
$2,064,210 |
D/D |
(40,775) |
43,431 |
|
68% |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2020-10-08 |
4 |
OE |
$1.00 |
$241,732 |
D/D |
25,779 |
84,206 |
|
- |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2020-10-05 |
4 |
AS |
$42.11 |
$421,128 |
D/D |
(10,000) |
421,974 |
|
108% |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2020-10-05 |
4 |
OE |
$5.90 |
$59,000 |
D/D |
10,000 |
431,974 |
|
- |
|
| Cournoyer Christine |
Director |
– • – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
407 |
11,848 |
|
- |
|
| Snyderman Ralph |
Director |
– • – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
370 |
84,457 |
|
- |
|
| Goldberg Michael |
Director |
– • – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,081 |
87,404 |
|
- |
|
| Bickerstaff George |
Director |
– • – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
444 |
90,487 |
|
- |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2020-10-01 |
4 |
AS |
$40.39 |
$809,972 |
D/D |
(20,000) |
421,974 |
|
117% |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2020-10-01 |
4 |
OE |
$5.49 |
$113,351 |
D/D |
20,000 |
441,974 |
|
- |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2020-09-30 |
4 |
AS |
$37.59 |
$638,802 |
D/D |
(16,992) |
421,974 |
|
138% |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2020-09-30 |
4 |
OE |
$5.49 |
$93,286 |
D/D |
16,992 |
438,966 |
|
- |
|
| Cohen Fred E |
Director |
– • – |
2020-09-21 |
4 |
OE |
$4.95 |
$84,905 |
D/D |
16,424 |
90,893 |
|
- |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2020-09-08 |
4 |
S |
$32.09 |
$3,209 |
D/D |
(100) |
421,974 |
|
-200% |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2020-09-08 |
4 |
AS |
$31.68 |
$313,609 |
D/D |
(9,900) |
422,074 |
|
200% |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2020-09-08 |
4 |
OE |
$5.49 |
$54,900 |
D/D |
10,000 |
431,974 |
|
- |
|
| Seeto Reginald |
See Remarks |
• – – |
2020-08-06 |
4 |
D |
$34.65 |
$14,310 |
D/D |
(413) |
121,849 |
|
- |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2020-08-06 |
4 |
D |
$34.65 |
$10,707 |
D/D |
(309) |
58,427 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2020-08-06 |
4 |
D |
$34.65 |
$21,448 |
D/D |
(619) |
110,277 |
|
- |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2020-08-05 |
4 |
AS |
$34.86 |
$478,339 |
D/D |
(13,008) |
421,974 |
|
88% |
|
789 Records found
|
|
Page 14 of 32 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.50 (3.2%) 
